Premium
Piramal Enterprises (earlier Piramal Healthcare) struck a blockbuster deal three years ago and sold the domestic formulation business to Abbott in a staggered transaction worth $3.7 billion. Since then, the cash-rich group has been investing in new businesses besides deploying cash in various assets. Early last year, it formed a ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
